Control of Cell Respiration and Apoptosis by Phosphorylation of Cytochrome c
通过细胞色素 c 磷酸化控制细胞呼吸和凋亡
基本信息
- 批准号:9982332
- 负责人:
- 金额:$ 35.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-08 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinity ChromatographyAmino AcidsAnimalsApoptosisApplications GrantsBacteriaBindingCandidate Disease GeneCattleCell DeathCell LineCell RespirationCellsCellular StressCessation of lifeCrystallographyCytoprotectionDataDiabetes MellitusDiseaseElectron TransportElectronsFunctional disorderGenerationsGlutamatesGoalsHeartIn VitroKidneyKnock-outKnockout MiceLaboratoriesLeadLeftLifeLiverMalignant NeoplasmsMapsMass Spectrum AnalysisMeasurementMediatingMembrane PotentialsMetabolicMethodsMitochondriaMitochondrial ProteinsModelingModificationMusNerve DegenerationNull LymphocytesOrganOxidative PhosphorylationOxygenPathologicPathway interactionsPharmacologyPhosphoric Monoester HydrolasesPhosphorylationPhosphorylation SitePhosphotransferasesPhysiologicalPlayPositioning AttributePost-Translational Protein ProcessingProcessProductionPropertyProtein DephosphorylationProteinsProtocols documentationRattusReactionReactive Oxygen SpeciesRegulationResearchRespirationRoleSignal PathwaySignal TransductionSignaling MoleculeStressStructureTechniquesTestingTissuesTransgenic MiceTransgenic OrganismsTyrosineVariantWaterWorkX-Ray Crystallographyadenylate kinaseapoptotic protease-activating factor 1basecytochrome ccytochrome c oxidaseexperienceexperimental studygenetic approachin vivomitochondrial membranemutantnoveloverexpressionpreventstress state
项目摘要
SUMMARY
Cytochrome c (Cytc) plays a central role in mitochondrial respiration and type 2
apoptosis. We have developed new protocols to purify mitochondrial proteins while
maintaining their physiological regulatory properties and posttranslational modifications,
and we discovered that Cytc is phosphorylated on distinct tyrosine residues in heart and
liver tissue. Recently, we have mapped two more phosphorylation sites on Cytc purified
from cow and rat kidneys, Thr28 and Ser47, which are the primary focus of this grant
application. Supported by strong preliminary data it is our overall hypothesis that Cytc
phosphorylation regulates the two main functions of Cytc, mitochondrial respiration and
apoptosis. Our long term goal is to understand the regulation of Cytc by cell signaling
pathways under normal and pathological conditions. As a first step towards our goal we
will test four specific hypotheses: 1) to test the hypothesis that kidney Cytc can be
phosphorylated on Thr28 and Ser47, and that these modifications affect the basic
properties of the molecule; 2) to test the hypothesis that Cytc Thr28 and Ser47
phosphorylation affects mitochondrial respiration and apoptosis; 3) to identify kinases
and phosphatases that control Cytc phosphorylation; and 4) to demonstrate the
physiological effect in mice. Phosphorylated Cytc will be isolated from cow and rat
kidneys and phosphomimetic mutant Cytc will be overexpressed and purified from
bacteria, followed by structural characterization using mass spectrometry, spectroscopic
methods, and protein crystallography (Aim 1). Phosphorylated and phosphomimetic
mutant Cytc will be subjected to a comprehensive set of functional analyses including in
vitro respiration and apoptosis measurements, and by in vivo studies with
phosphomimetic Cytc stably expressed in Cytc knockout cells (Aim 2). We will next lay
the ground work to explore the signaling pathways and identify kinases and
phosphatases that act on Cytc using affinity purification/mass spectrometry techniques
(Aim 3). Finally, we will reintroduce phosphomimetic and non-phosphorylatable mutant
Cytc into Cytc knockout mice to study the effect of Cytc modification and regulation at
the animal level (Aim 4). We expect that this research will reveal that Cytc, a protein that
makes life and death decisions, is subject to regulation by cell signaling, opening new
opportunities for the understanding of mitochondrial respiration and apoptosis, and to
control it in pathological conditions in which respiration and apoptosis are dysregulated.
摘要
细胞色素c(Cytc)在线粒体呼吸和2型呼吸中起核心作用。
细胞凋亡。我们开发了新的方案来纯化线粒体蛋白,同时
维持它们的生理调节特性和翻译后修饰,
我们发现Cytc在心脏和心脏中不同的酪氨酸残基上被磷酸化
肝组织。最近,我们在纯化的Cytc上又定位了两个磷酸化位点
来自牛和大鼠的肾脏,Thr28和Ser47,这是这笔赠款的主要重点
申请。在强劲的初步数据支持下,我们的总体假设是Cytc
磷酸化调节Cytc的两个主要功能,线粒体呼吸和
细胞凋亡。我们的长期目标是了解细胞信号对Cytc的调控。
正常和病理条件下的通路。作为迈向目标的第一步,我们
将测试四个具体的假设:1)测试肾脏细胞可以
Thr28和Ser47上的磷酸化,这些修饰会影响基本的
分子的性质;2)检验Cytc Thr28和Ser47假设
磷酸化影响线粒体呼吸和细胞凋亡;3)识别激酶
和控制Cytc磷酸化的磷酸酶;以及4)展示
对小鼠的生理影响。将从牛和大鼠中分离出磷酸化的Cytc
肾脏和仿磷突变体Cytc将从
细菌,然后使用质谱学进行结构表征,光谱
方法和蛋白质结晶学(目标1)。磷酸化和仿磷化
突变的Cytc将接受一套全面的功能分析,包括
体外呼吸和细胞凋亡的测量,并通过体内研究
拟磷脂酶C在Cytc基因敲除细胞中稳定表达(目标2)。我们接下来要做的是
基础工作是探索信号通路并识别激酶和
利用亲和纯化/质谱学技术研究作用于细胞色素C的磷酸酶
(目标3)。最后,我们将重新介绍拟磷化和非磷酸化突变体
将Cytc导入Cytc基因敲除小鼠,研究Cytc的修饰和调控作用
动物层面(目标4)。我们预计这项研究将揭示细胞色素C,一种可以
做出生死决定,受制于细胞信号的调节,打开新的
了解线粒体呼吸和细胞凋亡的机会,以及
在呼吸和细胞凋亡失调的病理条件下控制它。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
High Sucrose Diet-Induced Subunit I Tyrosine 304 Phosphorylation of Cytochrome c Oxidase Leads to Liver Mitochondrial Respiratory Dysfunction in the Cohen Diabetic Rat Model.
- DOI:10.3390/antiox13010019
- 发表时间:2023-12-21
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MAIK HUETTEMANN其他文献
MAIK HUETTEMANN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MAIK HUETTEMANN', 18)}}的其他基金
Development and Testing of LUCID: A Therapeutic Device for Brain Injury Following Infant Cardiac Arrest
LUCID 的开发和测试:婴儿心脏骤停后脑损伤的治疗装置
- 批准号:
10515831 - 财政年份:2022
- 资助金额:
$ 35.37万 - 项目类别:
Development and Testing of LUCID: A Therapeutic Device for Brain Injury Following Infant Cardiac Arrest
LUCID 的开发和测试:婴儿心脏骤停后脑损伤的治疗装置
- 批准号:
10708811 - 财政年份:2022
- 资助金额:
$ 35.37万 - 项目类别:
Non-invasive mitochondrial modulation therapy for ischemic stroke
缺血性中风的非侵入性线粒体调节疗法
- 批准号:
10352458 - 财政年份:2021
- 资助金额:
$ 35.37万 - 项目类别:
Non-invasive mitochondrial modulation therapy for ischemic stroke
缺血性中风的非侵入性线粒体调节疗法
- 批准号:
10231915 - 财政年份:2021
- 资助金额:
$ 35.37万 - 项目类别:
Non-invasive mitochondrial modulation therapy for ischemic stroke
缺血性中风的非侵入性线粒体调节疗法
- 批准号:
10583532 - 财政年份:2021
- 资助金额:
$ 35.37万 - 项目类别:
Infant NeuroLUX: A Novel Non-invasive Therapeutic Device for Neonatal Hypoxic Brain Injury
Infant NeuroLUX:一种治疗新生儿缺氧性脑损伤的新型非侵入性治疗装置
- 批准号:
10001121 - 财政年份:2019
- 资助金额:
$ 35.37万 - 项目类别:
Infant NeuroLUX: A Novel Non-invasive Therapeutic Device for Neonatal Hypoxic Brain Injury
Infant NeuroLUX:一种治疗新生儿缺氧性脑损伤的新型非侵入性治疗装置
- 批准号:
10017347 - 财政年份:2019
- 资助金额:
$ 35.37万 - 项目类别:
Control of Cell Respiration and Apoptosis by Phosphorylation of Cytochrome c
通过细胞色素 c 磷酸化控制细胞呼吸和凋亡
- 批准号:
9236889 - 财政年份:2017
- 资助金额:
$ 35.37万 - 项目类别:
Limiting brain reperfusion injury by controlling mitochondrial function
通过控制线粒体功能限制脑再灌注损伤
- 批准号:
9149032 - 财政年份:2015
- 资助金额:
$ 35.37万 - 项目类别:
Regulation of Respiration and Apoptosis by Cytochrome c Phosphorylation.
细胞色素 c 磷酸化对呼吸和细胞凋亡的调节。
- 批准号:
8306157 - 财政年份:2010
- 资助金额:
$ 35.37万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 35.37万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 35.37万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 35.37万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 35.37万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 35.37万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 35.37万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 35.37万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 35.37万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 35.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 35.37万 - 项目类别:
Collaborative Research and Development Grants